Letter to Editor: Observations of Deception in Urine Drug Testing

Ann Clin Lab Sci. 2023 Jul;53(4):671-672.

Abstract

Objective: Determining deception in urine drug testing. Some of the patients undergoing urine drug tests have not taken the prescribed drug and attempt to deceive the laboratory test by placing the parent drug in the collection cup.

Methods: One of the ways to determine if this is occurring is to monitor the major metabolite of the drug. By using the metabolite/parent drug ratio this attempt at deception can be uncovered.

Results: Of the five drugs we examined, oxycodone, hydrocodone, buprenorphine, methadone, and fentanyl, we found buprenorphine to be the most prevalent drug to this type of deception.

Conclusion: Deception can be identified using the metabolite/parent drug ratio.

Keywords: Deception; buprenorphine; outliers; urine drug tests.

Publication types

  • Letter

MeSH terms

  • Buprenorphine*
  • Deception
  • Fentanyl
  • Humans
  • Hydrocodone
  • Substance Abuse Detection*

Substances

  • Buprenorphine
  • Fentanyl
  • Hydrocodone